Defining the level of evidence for technology adoption in the localized prostate cancer pathway.

Détails

Ressource 1Demande d'une copie Sous embargo indéterminé.
Accès restreint UNIL
Etat: Public
Version: Final published version
ID Serval
serval:BIB_AD52F90960C9
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Synthèse (review): revue aussi complète que possible des connaissances sur un sujet, rédigée à partir de l'analyse exhaustive des travaux publiés.
Collection
Publications
Institution
Titre
Defining the level of evidence for technology adoption in the localized prostate cancer pathway.
Périodique
Urologic Oncology
Auteur⸱e⸱s
Valerio M., El-Shater Bosaily A., Emberton M., Ahmed H.U.
ISSN
1873-2496 (Electronic)
ISSN-L
1078-1439
Statut éditorial
Publié
Date de publication
2014
Peer-reviewed
Oui
Volume
32
Numéro
6
Pages
924-930
Langue
anglais
Notes
Publication types: REVIEW Publication Status: ppublish PDF: Seminar article
Résumé
New technologies in prostate cancer are attempting to change the current prostate cancer pathway by aiming to reduce harms while maintaining the benefits associated with screening, diagnosis, and treatment. In this article, we discuss the optimal evaluation that new technologies should undergo to provide level 1 evidence typically required to change the practice. With this in mind, we focus on feasible and pragmatic trials that could be delivered in a timely fashion by many centers while retaining primary outcomes that focus on clinically meaningful outcomes.
Pubmed
Web of science
Open Access
Oui
Création de la notice
05/09/2014 18:11
Dernière modification de la notice
20/08/2019 16:17
Données d'usage